Iressa
Sponsors
M.D. Anderson Cancer Center, National Taiwan University Hospital, Baylor Breast Care Center, Stanford University, Case Comprehensive Cancer Center
Conditions
Breast CancerEsophageal CancerHead and Neck CancerLocally Advanced Prostate CancerLung CancerNon-Small Cell Lung CancerNon-small Cell Lung CancerSkin Cancer
Phase 1
A Phase I/II Study of Bexarotene in Combination With ZD1839 (IRESSA®) in the Treatment of Non-Small Cell Lung Cancer
CompletedNCT00238628
Start: 2004-04-30End: 2005-12-31Target: 12Updated: 2010-07-20
Cisplatin, Fluorouracil, Iressa, and Radiation Therapy Patients With Locally Advanced Head and Neck Cancer
CompletedNCT00352105
Start: 2006-04-30End: 2010-05-31Updated: 2012-11-05
Phase 2
ZD1839 (Iressa) for Recurrent or Metastatic Squamous Cell Carcinoma of the Skin
CompletedNCT00054691
Start: 2004-05-31End: 2012-10-31Updated: 2015-03-13
Iressa as a First-Line Treatment in Chemonaive Patients With Inoperable Non-Small Cell Lung Cancer
CompletedNCT00173875
Start: 2005-03-31End: 2007-07-31Updated: 2007-07-30
Trial of ZD1839 (Iressa) and Tamoxifen in Breast Cancer Patients
TerminatedNCT00206492
Start: 2003-07-31End: 2006-10-31Updated: 2017-08-01
Radiotherapy,Chemotherapy,Before and After Surgery in Advanced Esophageal or Gastroesophageal Junction Cancer
CompletedNCT00258323
Start: 2005-10-31End: 2010-02-28Updated: 2015-09-30
Combination Casodex® and Iressa™ in Locally Advanced Prostate Cancer
CompletedNCT00319787
Start: 2003-12-31End: 2006-08-31Target: 102Updated: 2011-01-25